Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
01/2004
01/01/2004US20040001895 Combination treatment for depression and anxiety
01/01/2004US20040001881 Drug in pressure sensitive adhesive; vomiting, nausea therapy; side effect reduction
01/01/2004US20040001875 Antidiabetic agents; controlling concentration of protein, carbohydrates, fats
01/01/2004US20040001873 Gelled delivery vehicle containing nutritional ingredients
01/01/2004US20040001868 Aerosol mixture of lipid crystals with propellant
01/01/2004US20040001841 Use of biomolecular targets in the treatment and visualization of brain tumors
01/01/2004US20040001840 Cancer-linked gene as target for chemotherapy
01/01/2004US20040001835 Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
01/01/2004US20040001833 Method of treating cancer using kinase inhibitors
01/01/2004US20040001817 Mixture of vitamions, minerals, digestive enzyme, hormone and amino acids
01/01/2004US20040001792 Decoloring hair and skin using ascorbic acid
12/2003
12/31/2003WO2004001655A1 Methods of treating and preventing colitis involving il-13 and nk-t cells
12/31/2003WO2004001410A1 Methods for identifying glucose uptake modulators
12/31/2003WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003WO2004001072A2 Method for diagnosis of colorectal tumors
12/31/2003WO2004001068A2 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003WO2004001059A2 Heterocyclic inhibitors of kinases
12/31/2003WO2004001047A1 Novel promoter
12/31/2003WO2004001035A1 Method for generating monoclonal antibodies
12/31/2003WO2004001014A2 Osteopontin, oligodendrocytes and myelination
12/31/2003WO2004001002A2 Novel anticholesterol compositions and method for using same
12/31/2003WO2004000875A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003WO2004000858A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/31/2003WO2004000856A1 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
12/31/2003WO2004000855A1 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd
12/31/2003WO2004000849A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
12/31/2003WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003WO2004000831A1 Indole derivatives useful as histamine h3 antagonists
12/31/2003WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003WO2004000807A1 Cannabinoid receptor agonists
12/31/2003WO2004000805A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003WO2004000801A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
12/31/2003WO2004000790A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003WO2004000788A1 Ureido-substituted aniline compounds useful as serine protease inhibitors
12/31/2003WO2004000372A2 Disinfecting composition, cleaning tablet produced therefrom, and use thereof
12/31/2003WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003WO2004000357A1 Potentiating the antipyretic action of nonopioid analgesic
12/31/2003WO2004000356A1 Medicinal composition containing diuretic and peroxisome proliferator-activated receptor (ppar) ϝ actiavtor
12/31/2003WO2004000355A1 Combination treatment for depression and anxiety by nk1 and nk3 antagonists
12/31/2003WO2004000354A2 Method of treating the syndrome of lipodystrophy
12/31/2003WO2004000353A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
12/31/2003WO2004000335A1 Lactic acid bacteria cultures that inhibit food-borne pathogens
12/31/2003WO2004000331A1 Organ arrest, protection, preservation and recovery
12/31/2003WO2004000329A1 Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors
12/31/2003WO2004000326A1 Combination therapy wherein a serotonin reuptake inhibitor is used
12/31/2003WO2004000316A1 Use of mglur5 antagonists for the treatment of gerd
12/31/2003WO2004000311A2 Pharmaceutical composition comprising calcium channel blockers for the treatment of pain
12/31/2003WO2004000310A1 Medicament for the treatment of the systemic inflammatory response syndrome
12/31/2003WO2004000297A1 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
12/31/2003WO2004000293A2 Use of taurine or derivatives thereof for the treatment of alopecia
12/31/2003WO2004000291A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails
12/31/2003WO2004000277A1 Resorbable delivery systems for the treatment of cancer
12/31/2003WO2004000275A1 Transdermal aerosol compositions
12/31/2003WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003WO2004000229A2 Treatment of human multiple myeloma by curcumin
12/31/2003WO2004000226A2 Liposomes containing biologically active compounds
12/31/2003WO2004000225A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003WO2004000224A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003WO2004000223A2 Rapidly disintegrating formulations for treating or preventing mucositis
12/31/2003WO2004000219A2 Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
12/31/2003WO2004000205A2 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000197A2 Quick dissolve compositions and tablets based thereon
12/31/2003WO2004000116A1 Devices and methodologies useful in body aesthetics
12/31/2003WO2004000045A2 Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof
12/31/2003WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
12/31/2003WO2004000025A1 Use of a composition and a cleaning tablet containing said composition for disinfecting purposes
12/31/2003WO2004000016A2 Antimicrobial compositions, products and methods employing same
12/31/2003WO2003087308A3 Use of interleukin-24 to treat ovarian cancer
12/31/2003WO2003082372A3 Chemiluminescent treatment of acne
12/31/2003WO2003080021A3 Formulation comprising buprenorphine
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003WO2003061573A3 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
12/31/2003WO2003059288A3 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
12/31/2003WO2003059269A3 Acridone inhibitors of impdh enzyme
12/31/2003WO2003057172A3 Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses
12/31/2003WO2003055912A3 Secreted proteins
12/31/2003WO2003052138A3 Methods of detecting modification of genetic material
12/31/2003WO2003049746A3 Combination of cytochome p450 dependent protease inhibitors
12/31/2003WO2003047606A3 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors
12/31/2003WO2003020759A9 A caspase- 8 binding protein, its preparation and use
12/31/2003WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis
12/31/2003WO2002070562A3 Nuclear hormone receptor ligand binding domain
12/31/2003WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003WO2002042444A3 Fungal gene cluster associated with pathogenesis
12/31/2003WO2002040671A3 Immunoglobulin superfamily proteins
12/31/2003WO2002038143A3 Enhanced efficacy and safety of genotoxic therapy by p38 mapk modulation
12/31/2003WO2002023199A8 Method, system, apparatus and device for discovering and preparing chemical compounds
12/31/2003CN1464908A Multivalent antibodies and uses therefor
12/31/2003CN1464881A New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
12/31/2003CN1464878A Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
12/31/2003CN1464790A T cell receptor fusions and conjugates and methods of use thereof
12/31/2003CN1463703A Nasal cavity preparation for treating long-term allergic reaction coryza
12/31/2003CN1132586C Immunomodulating compositions from bile
12/31/2003CN1132581C Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitiors
12/31/2003CN1132578C Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals
12/31/2003CN1132573C Long-lasting composition for rectal administration
12/31/2003CN1132557C 靶向局部治疗疾病的装置 Targeting apparatus topical treatment of diseases
12/31/2003CA2715558A1 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
1 ... 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 ... 1151